We use cookies to give you the best online experience. By using our website you agree to our use of cookies in accordance with our cookie policy. Learn more
Menu Search : Roche in the news

You are here:

  1. Media
  2. Roche in the news
  • Home
  • About Roche
  • Therapy Areas
  • Patient Support Program
  • Media
  • Careers
  • Contact Us

Roche in the news

 

 

Roche in the news

 

Roche Launches Antibody Drug for Breast Cancer in India

Single-shot breast cancer drug to cut treatment time by 90%

Govt of Punjab, Roche Pharma India and Niramai Health Analytix partner to accelerate Breast Cancer management

Roche and Delhi State Cancer Institute (DSCI) partner to strengthen the Cancer Care ecosystem in Delhi

New Hope, Funding Approaches As Roche Brings Evrysdi To India

Roche's oral therapy 'Evrysdi' to provide cost-effective alternative against fatal genetic disorder SMA in India

Roche launches spinal muscular atrophy treatment drug in India priced at around Rs 6 lakh per bottle

Evrysdi has ushered a new journey of hope for patients living with SMA in India: V Simpson Emmanuel

Vaccine allowance of Rs 5,000 for each employee of Roche Pharma India

Roche's COVID Antibody Cocktail Can Reduce Hospitalisation By 70 Per Cent: CEO Simpson

All about antibody cocktail drug to fight COVID

Antibody cocktail out in market at Rs 59k/dose

Antibody cocktail launched in India

COVID antibody cocktail used to treat Donald Trump now launched in India 

Additional 45,000 Vials of Covid-19 Drug Tocilizumab Allocated to States: Gowda

Roche seeking fast approval of antibody cocktail in India to treat Covid

Roche Pharma launches drug to treat breast cancer

Share
  • Share via email
  • Share on Facebook
  • Share on Twitter
  • Share on LinkedIn
  • Share on Google+
  • Share on Xing
Close
  • © 2023
  • 12 September, 2022
  • Careers
  • Contact
  • Legal Statement
  • Privacy Policy
  • Cookie Preferences.

Disclaimer to be added as a part of Privacy Policy : This website contains information on products which is targeted to a wide range of audiences and could contain product details or information otherwise not accessible or valid in your country. Please be aware that we do not take any responsibility for accessing such information which may not comply with any legal process, regulation, registration or usage in the country of your origin. This website is neither intended nor designed to record or report adverse event information. If you have a suspected side effect or problem to report regarding one of our products, visit us at https://www.rocheindia.com/en/contact.html OR please call the Roche India Safety Unit on +91-98201 63752 or E-mail us at [email protected]